Bioethical implications of current state practices of molecular diagnostics in neuropathology
Neuro Oncol
.
2022 Jun 1;24(6):853-854.
doi: 10.1093/neuonc/noac058.
Authors
Wesley Wang
1
,
Dana Howard
2
,
Pierre Giglio
3
,
Diana Thomas
1
4
,
José Javier Otero
1
Affiliations
1
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
2
Department of Bioethics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
3
Department of Neuro-Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
4
Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
PMID:
35381085
PMCID:
PMC9159437
DOI:
10.1093/neuonc/noac058
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
MeSH terms
Humans
Nervous System Diseases*
Pathology, Molecular*
Grants and funding
TL1 TR002735/TR/NCATS NIH HHS/United States
R03 NS116334/NS/NINDS NIH HHS/United States
UL1 TR001450/TR/NCATS NIH HHS/United States